PFA Investor Call Intimation.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the stock exchanges about its Q4 FY2025 earnings conference call scheduled for 30th April 2025 at 4:30 PM IST, following the Board meeting to approve audited financial results. The leadership team will discuss the company's financial performance and answer investor questions during the one-hour call. International dial-in numbers have been provided for investors in the USA, UK, Hong Kong, and Singapore, and a transcript will be posted on the company's website after the call. The company noted this is a re-upload of an earlier intimation that was not visible on BSE.
This is a routine procedural announcement with no direct impact on stock price. Investors should watch the call for management commentary on Q4 FY25 revenue, margins, and FY26 guidance, which could shape near-term sentiment.